Journal of Indian Society of Periodontology
Journal of Indian Society of Periodontology
Home | About JISP | Search | Accepted articles | Online Early | Current Issue | Archives | Instructions | SubmissionSubscribeLogin 
Users Online: 423  Home Print this page Email this page Small font size Default font size Increase font sizeWide layoutNarrow layoutFull screen layout
Ahead of Print

Case report on low dose of Cilnidipine: A fourth-generation calcium channel blocker-induced gingival overgrowth

 Department of Periodontics, KMCT Dental College, Kozhikode, Kerala, India

Correspondence Address:
Sameera Gopinath,
20/1312, “Krishneeyam”, Thiruvannur Road, Panniyankara, Kallai Post, Kozhikode - 673 003, Kerala, India
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/jisp.jisp_557_18

Drug-induced gingival overgrowth is a frequently observed adverse effect of antihypertensive drug calcium channel blockers (CCBs). Gingival enlargements are more common with the dihydropyridine class of CCBs. The fourth-generation dihydropyridine CCB Cilnidipine was introduced in 1995 and is used as an antihypertensive agent for patients in the Indian subcontinent. This is the first report in literature to document an isolated case of generalized gingival overgrowth induced by the long-term use of low dose of cilnidipine in an elderly female patient who is under antihypertensive therapy. Gingival overgrowth is an adverse drug reaction of new-generation CCB Cilnidipine when administered even as low-dose antihypertensive therapy agent. Physicians and dentists should identify such late changes in susceptible individuals.

Print this article
  Search Pubmed for
    -  Gopinath S
    -  Harishkumar VV
    -  Santhosh VC
    -  Puthalath S
 Citation Manager
 Article Access Statistics
 Reader Comments
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded24    

Recommend this journal